Suppr超能文献

Augment(®) 骨移植对血小板衍生生长因子血清浓度的影响:一项药代动力学研究。

Effect of implantation of Augment(®) Bone Graft on serum concentrations of platelet-derived growth factors: a pharmacokinetic study.

机构信息

BioMimetic Therapeutics Inc., 389 Nichol Mill Lane, Franklin, TN 37067, USA.

出版信息

Clin Drug Investig. 2013 Feb;33(2):143-9. doi: 10.1007/s40261-013-0053-5.

Abstract

BACKGROUND

Augment(®) Bone Graft is a bone graft substitute intended to be used as an alternative to autologous bone graft in the fusion of hindfoot and ankle joints. Augment(®) Bone Graft is a combination device comprised of beta-tricalcium phosphate (β-TCP) and recombinant human platelet-derived growth factor BB homodimer (rhPDGF-BB).

OBJECTIVE

This human pharmacokinetic study was undertaken to assess the effect of Augment(®) Bone Graft implantation on the serum concentration of platelet-derived growth factors (PDGFs).

METHODS

Under the terms of a Research Ethics Board-approved protocol, Augment(®) Bone Graft was implanted in patients (n = 7) undergoing hindfoot and ankle arthrodesis procedures requiring graft material. The control cohort of the study (n = 4) received autologous bone graft. The serum concentrations of PDGF isoforms AA, AB and BB in blood samples, obtained prior to and at ten time points (up to 7 days) after surgery, were measured using enzyme-linked immunosorbent assays (ELISA).

RESULTS

The serum concentration of PDGF-BB did not vary significantly from baseline (median of the combined cohorts 3.89 ng/mL) throughout the course of the study. The serum concentrations of PDGF-AA, PDGF-AB and total PDGF did not deviate from their baseline values (medians of the combined cohorts were 2.87, 14.95 and 20.19 ng/mL for PDGF-AA, PDGF-AB and total PDGF, respectively) except for the last time point in which they were increased (medians for the combined cohorts were 4.71, 20.42 and 30.29 ng/mL for PDGF-AA, PDGF-AB and total PDGF, respectively). There were no differences between the two treatment groups with regard to changes in the serum concentrations of PDGF. None of the samples tested contained anti-PDGF-BB antibodies.

CONCLUSION

Analysis of the data demonstrated that the serum concentrations of all three PDGF isoforms analysed were unaffected by implantation of Augment(®) Bone Graft.

摘要

背景

Augment(®)骨移植物是一种骨移植物替代物,旨在替代后足和踝关节融合中的自体骨移植物。Augment(®)骨移植物是一种由β-磷酸三钙(β-TCP)和重组人血小板衍生生长因子 BB 同二聚体(rhPDGF-BB)组成的组合装置。

目的

进行这项人体药代动力学研究是为了评估 Augment(®)骨移植物植入对血小板衍生生长因子(PDGFs)血清浓度的影响。

方法

根据伦理委员会批准的方案条款,在需要移植物材料的后足和踝关节关节融合手术中,将 Augment(®)骨移植物植入患者(n=7)。研究的对照组(n=4)接受自体骨移植物。使用酶联免疫吸附试验(ELISA)在术前和术后十个时间点(最多 7 天)采集的血样中测量 PDGF 同种型 AA、AB 和 BB 的血清浓度。

结果

在整个研究过程中,PDGF-BB 的血清浓度从基线(联合队列的中位数 3.89ng/mL)没有显著变化。PDGF-AA、PDGF-AB 和总 PDGF 的血清浓度没有偏离其基线值(联合队列的中位数分别为 2.87、14.95 和 20.19ng/mL),除了最后一个时间点有所增加(联合队列的中位数分别为 4.71、20.42 和 30.29ng/mL)。两组间 PDGF 血清浓度的变化无差异。没有一个测试样本含有抗 PDGF-BB 抗体。

结论

数据分析表明,分析的三种 PDGF 同种型的血清浓度均不受 Augment(®)骨移植物植入的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验